Skip to main content
. 2019 Sep 2;116(35-36):592–599. doi: 10.3238/arztebl.2019.0592

Table 2. Primary and secondary outcome measures at participants’ final follow-up.

IG CG IG CG
n Mean (SD) Mean (SD) b [95% CI] p AAP AAP SMD ICC
Quality of life (EORTC QLQ-C30)*1
Role functioning 378 60.83 (28.89) 57.64 (29.05) 3.69 [−2.00; 9.39] 0.204 61.11 57.42 0.13 0.01
General health 375 59.36 (22.09) 57.82 (22.96) 1.44 [−3.18; 6.06] 0.540 59.59 58.15 0.06 0.09
Physical functioning 379 76.00 (19.52) 72.82 (21.45) 2.89 [−0.40; 6.18] 0.085 75.86 72.97 0.14 0.00
Emotional functioning 377 55.23 (24.93) 55.69 (25.03) 0.38 [−4.12; 4.88] 0.868 55.64 55.25 0.02 0.00
Cognitive functioning 377 64.64 (26.97) 66.67 (25.77) −0.44 [−5.00; 4.12] 0.851 65.40 65.84 −0.02 0.00
Social functioning 377 63.20 (29.03) 61.94 (30.32) 1.39 [−4.10; 6.89] 0.619 63.26 61.87 0.05 0.00
Pain 378 34.86 (29.46) 37.11 (31.32) −3.84 [−9.60; 1.92] 0.191 33.97 37.81 −0.13 0.05
Fatigue 377 49.69 (24.34) 50.40 (25.70) −1.42 [−5.96; 3.13] 0.541 49.35 50.77 −0.06 0.00
Fatigue (EORTC FA13)*1
Physical fatigue 378 49.11 (26.66) 49.63 (25.44) −1.80 [−6.67; 3.06] 0.467 48.49 50.30 −0.07 0.00
Emotional fatigue 378 35.38 (25.92) 34.88 (26.84) 0.19 [−.55; 4.93] 0.937 35.23 35.04 0.00 0.02
Cognitive fatigue 378 22.87 (21.53) 20.63 (21.34) 1.89 [−1.83; 5.60] 0.320 22.70 20.81 0.09 0.00
Problems affecting daily life 375 44.33 (30.07) 43.26 (30.61) 0.82 [−4.89; 6.53] 0.778 44.21 43.39 0.03 0.00
Social consequences of fatigue 372 23.54 (30.37) 26.22 (32.07) 1.51 [−3.99; 7.01] 0.590 25.54 24.03 0.05 0.00
Coping with illness (FKV)*2
Active problem-oriented coping 378 2.75 (0.89) 2.85 (0.90) −0.12 [−0.29; 0.05] 0.155 2.74 2.86 −0.14 0.00
Depressive coping 378 2.02 (0.80) 2.03 (0.84) −0.01 [−0.16; 0.14] 0.869 2.02 2.03 −0.02 0.00
Distraction and self-encouragement 378 3.07 (0.87) 3.02 (0.86) 0.02 [−0.13; 0.18] 0.764 3.05 3.03 0.03 0.00
Work-related outcomes
Work Ability Score*3 372 5.59 (2.59) 5.85 (2.62) −0.26 [−0.78; 0.26] 0.323 5.60 5.86 −0.10 0.05
Disability days during past 3 months 323 9.44 (20.43) 10.26 (22.48) −0.79 [−5.96; 4.37] 0.764 9.56 10.35 −0.04 0.12

We used mixed-effects models to calculate test statistics, controlled for the values of the initial survey.

AAP, Average adjusted predictions; b, non-standardized regression coefficient; CG, control group; CI, confidence interval; EORTC, European Organization for Research and Treatment of Cancer; FA, fatigue; FKV, Freiburg Questionnaire of Coping with Illness; ICC, intracluster correlation coefficient; IG, intervention group;

QLQ, Quality of Life Questionnaire; SD, standard deviation; SMD, standardized mean difference

*1 Maximum achievable score = 100; *2 maximum achievable score = 5; *3 maximum achievable score = 10